RV7 trade ideas
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASHALO: Halozyme Therapeutics, Inc.
2021-01-15 17:00:00
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis
HALO Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
$HALO, Bio BreakoutYet another #biotech #breakout - Latest quarter showed a +290% earnings improvement. This #biopharma has a $4B market cap. Watching, not buying.
BUY to HALOZYME THERAPEUTICS DailyHey people, HALOZYME THERAPEUTICS is in a bullish continuation a small rejection of the sellers but that changes to nothing large volume of purchases made. Great possibility of breaking with force the median this time to reach the next point, which is the double of the candle and to start again lower if the buyers are too expensive.
Please LIKE & FOLLOW, thank you!!
Halozyme Announces Roche Receives FDA Approval For Phesgo(TM) (FHALO: Halozyme Therapeutics, Inc.
2020-06-29 12:54:00
Halozyme Announces Roche Receives FDA Approval For Phesgo(TM) (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With HER2-Positive Breast Cancer
HALO Bearish Divergence In PlayHello,
What is HALO?
Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.
News
My Thoughts For You
We are in a correction as the weekly TF is showing a Bearish Divergence. I have provided a snapshot below.
Good Luck, Cheers!
Be sure to comment, follow, like, and check out my profile for more trade ideas!
Halozyme Therapeutics (HALO - US) ABC wave patternHalozyme Therapeutics (#HALO - US) is in ABC pattern and out-performing the SPX. It is in internal 4th wave correction of 3rd wave of C up. Buy at the price within box, if possible for the new high as target.
HALO - Potential 5th ElliottWave Swing Trading OpportunityUsing our Elliott Wave Indicator Suite for the TradingView Platform we have identified a potential Long 5th Wave Swing Trading Opportunity for HALO on the Daily time frame . The 5th wave move in an elliottwave sequence is the highest probability move. The large impulse moves, waves 1 and 3, were obvious news events with large volume. The volume on the wave 4 pull back has stared to run out of juice, which is a good sign.
The wave 4 pull back has found support in the Red zone of our probability pullback zones, which represents an 75% probability that our automated 5th wave target zone, in blue on the chart, will be hit. Further more the profit taking pull back is at major support and resistance zone from previous range period.
We see yellow dots formed in the overbought zone on our special False Breakout Stochastic indicator, which signals strong Bullish momentum. When, during a wave 4 pullback, the stochastic pulls back against these false break out dots and crosses in the oversold zone, there is a high probability the stocks price action will resume the overall bullish trend .
We also measure the wave 4 behaviour with our Elliottwave oscillator, which has pulled back within our pre-determined zone.
So overall we have identified, using our Elliott Wave Indicator suite for TradingView, a high probability long swing trading opportunity for HALO , Weekly Time Frame , with the following entry strategy:
We use our 6/4 MA High for initial starting point for long entries and take into consideration and recent pivots during the 4th wave pullback.
Long entry through $18.63
Stop Loss $17.63
Target $20.20
Giving a Risk to Reward of 1:1.7
HALO at 18.08 possible in the next 7-10 daysThis is based purely on Fib retracements and trend-based timing.
Long HALO - Retest of Accumulation ZoneCould go long on this retest of the accumulation zone. Price Target $18.50.
HAlo- Need to Hold 12.7512.75 is the hold here. If can hold this and come back with a bullish candle to follow up this should be a good r/r here.
Good Risk to RewardHALO saw poor demand into resistance followed by an increase in selling pressure. This is usually characteristic of DISTRIBUTION; however, price did not close below support. This is because demand exceeded supply.
This is a signs that BULLS are attempting to "absorb" supply.
Even in the face of indecision longs have an opportunity to buy support offering a good risk to reward.
Good Luck!
